CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale Chief Development Officer sold 20,000 shares at $5.27 ($105,476)
- 4 Planned sale Chief Development Officer sold 10,272 shares at $5.00 ($51,360)
- 4 Planned sale Chief Development Officer sold 3,000 shares at $4.50 ($13,500)
- 4 Open-market sale Chief Medical Officer sold 2,581 shares at $4.36 ($11,259)
- 4 Open-market sale Chief Development Officer sold 3,767 shares at $4.36 ($16,432)
- 4 Open-market sale Chief Commercial Officer sold 4,714 shares at $4.36 ($20,563)
- 4 Open-market sale Chief Financial Officer sold 2,873 shares at $4.36 ($12,533)
- 4 Open-market sale President & CEO sold 11,368 shares at $4.36 ($49,589)
- 4 Open-market sale GRAMMER ELIZABETH A sold 2,384 shares at $4.36 ($10,399)
- 4 Open-market sale Felsch Robert Ora sold 1,044 shares at $4.36 ($4,554)
- 4 Open-market sale Blanks Robert sold 2,835 shares at $4.36 ($12,367)
- 4 Open-market sale Chief Medical Officer sold 25,000 shares at $4.00 ($99,998)
- 4 Planned sale Chief Development Officer sold 1,644 shares at $4.00 ($6,576)
- 4 Planned sale Chief Development Officer sold 2,897 shares at $4.55 ($13,181)
- 4 Open-market sale Chief Commercial Officer sold 4,733 shares at $3.55 ($16,811)
- 4 Open-market sale Chief Medical Officer sold 2,591 shares at $3.55 ($9,203)
- 4 Open-market sale Chief Development Officer sold 3,783 shares at $3.55 ($13,436)
- 4 Open-market sale Chief Financial Officer sold 2,884 shares at $3.55 ($10,243)
- 4 Open-market sale President & CEO sold 11,419 shares at $3.55 ($40,558)
- 4 Open-market sale GRAMMER ELIZABETH A sold 2,392 shares at $3.55 ($8,496)
Page 11 of 35 · 696 filings